The emergence of H7N9 viruses: a chance to redefine correlates of protection for influenza virus vaccines

This publication has 24 references indexed in Scilit:

• Characterization of H7N9 influenza A viruses isolated from humans
  Nature, 2013
• Receptor binding by an H7N9 influenza virus from humans
  Nature, 2013
• Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
  The Lancet, 2013
• Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
  New England Journal of Medicine, 2013
• Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans
  PLOS ONE, 2012
• Broadly neutralizing antibodies against influenza virus and prospects for universal therapies
  Current Opinion in Virology, 2012
• Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
  Proceedings of the National Academy of Sciences, 2012
• A cell‐based H7N1 split influenza virion vaccine confers protection in mouse and ferret challenge models
  Influenza and Other Respiratory Viruses, 2009
• A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
  Vaccine, 2009
• The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses
  Epidemiology and Infection, 1972